Literature DB >> 2842049

Clinical presentation and neuropharmacology of restless legs syndrome.

A S Walters1, W Hening.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2842049     DOI: 10.1097/00002826-198706000-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  8 in total

1.  Low plasma iron status and akathisia.

Authors:  T Tarao; R Yoshimura
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

Review 2.  Aetiology and treatment of sleep disturbances during perimenopause and postmenopause.

Authors:  P Polo-Kantola; T Saaresranta; O Polo
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Restless legs and periodic leg movements in sleep syndromes.

Authors:  T C Wetter; T Pollmächer
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

4.  Restless legs syndrome in the elderly.

Authors:  S T O'Keeffe; J Noel; J N Lavan
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

Review 5.  Restless legs syndrome: pathophysiology, diagnosis and treatment.

Authors:  Pankaj Satija; William G Ondo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 6.  Restless legs syndrome and pain disorders: what's in common?

Authors:  Leonardo Ierardi Goulart; Raimundo Nonato Delgado Rodrigues; Mario Fernando Prieto Peres
Journal:  Curr Pain Headache Rep       Date:  2014-11

7.  Restless legs syndrome as a comorbidity in rheumatoid arthritis.

Authors:  John A Gjevre; Regina M Taylor Gjevre
Journal:  Autoimmune Dis       Date:  2013-06-12

8.  Prevalence of restless legs syndrome and associated risk factors among middle-aged Saudi population.

Authors:  Siraj Omar Wali; Bahaa Abaalkhail
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.